Becton Dickinson and : 2021 Annual Shareholder Meeting Presentation
January 26, 2021 at 04:58 pm
Share
2021
Annual Meeting of Shareholders
January 26, 2021
1
Call to order
Vincent A. Forlenza
Executive Chairman
of the Board
Tom Polen
Director
CEO and President
2
Catherine M. Burzik
Director (G, Q, S)
Christopher Jones Director (C, G, Q)
Rebecca W. Rimel
Director (A, S)
R. Andrew Eckert
Director (A, S)
Marshall O. Larsen Director (C, G, Q)
Timothy M. Ring
Director (Q, S)
Claire M. Fraser, Ph.D.
Director (G, Q, S)
David F. Melcher
Director (A, C)
Bertram L. Scott
Director (A, C)
Jeffrey W. Henderson
Director (A, C)
Claire Pomeroy, MD
Director (G, Q, S)
Board Committee Legend
A = Audit
C = Compensation
G = Governance
Q = Quality & Regulatory
S = Science, Marketing,
Innovation & Technology
Meeting Matters
Introduction of proposals
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
BD - Becton, Dickinson and Company published this content on 26 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 January 2021 21:57:01 UTC
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
BECTON, DICKINSON AND COMPANY 
